Short-term outcomes of laparoscopic single anastomosis gastric bypass (LSAGB) for the treatment of type 2 diabetes in lower BMI (<30 kg/m 2) patients

Obesity Surgery

Volumn 24, Issue 7, 2014, Pages 1044-1051

  Kim, Myung Jin ^a   Hur, Kyung Yul ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Gastric bypass; Metabolic surgery; Type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; PROTON PUMP INHIBITOR; ZINC; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ANASTOMOSIS; ANASTOMOSIS LEAKAGE; ARTICLE; BODY MASS; CONTROLLED STUDY; CONVERSION TO OPEN SURGERY; DESQUAMATION; DIABETIC PATIENT; DISEASE DURATION; ENTEROCUTANEOUS FISTULA; FEMALE; FOLLOW UP; GASTROINTESTINAL STAPLER; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HOSPITAL READMISSION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; IRON DEFICIENCY ANEMIA; IRON THERAPY; JEJUNUM ULCER; LAPAROSCOPIC SINGLE ANASTOMOSIS GASTRIC BYPASS; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ODYNOPHAGIA; OPERATION DURATION; OUTCOME ASSESSMENT; PATIENT HISTORY OF NEPHRECTOMY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; ROUX Y ANASTOMOSIS; STOMACH ANTRUM; STOMACH BYPASS; STOMACH POUCH; STOMATITIS; SURGICAL INFECTION; TISSUE ADHESION; WEIGHT REDUCTION; ZINC BLOOD LEVEL; AGED; BLOOD; DIABETES MELLITUS, TYPE 2; LAPAROSCOPY; LENGTH OF STAY; METABOLISM; MIDDLE AGED; REMISSION; TREATMENT OUTCOME;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LAPAROSCOPY; LENGTH OF STAY; MALE; MIDDLE AGED; REMISSION INDUCTION; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84904416896     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-014-1202-5     Document Type: Article

References (47)

1. Zimmer P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-87. (Pubitemid 34000780)
2. Guh DP, Zhang W, Bansback N, et al. The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.
3. Korea Health Statistics 2010: Korea National Health and Nutrition Examination Study, the Ministry of Health and Welfare, 2010 (http://knhanes.cdc. go.kr) (KNHANES V-1).
4. Chan JM, Rimm EB, Colditz GA, et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961-9. (Pubitemid 24268605)
5. Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481-6.
6. Ambady R, Ronald Ching WM, Chamukuttau S. Diabetes in Asia. Lancet. 2010;375:408-18.
7. Juliana CN, Vasanti M, Weiping J, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129-37.
8. Oh JY, Hong YS, Sung YA, et al. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care. 2004;27:2027-32. (Pubitemid 38989250)
9. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-37. (Pubitemid 39346675)
10. Mingrone G, DeGaetano A, Greco AV, et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia. 1997;40:599-605. (Pubitemid 27186798)
11. Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28:628-42.
12. Rutledge R. The mini-gastric bypass: experience with the first 1274 cases. Obes Surg. 2001;11:276-80. (Pubitemid 32607215)
13. Pories WJ, Albrecht RJ. Etiology of type 2 diabetes mellitus: role of the foregut. World J Surg. 2001;25:527-31. (Pubitemid 32455209)
14. Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002;236:554-9. (Pubitemid 35246885)
15. Scott EG, Frank LG, Stanley K. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg. 2002;137:1109-17.
16. American Diabetes Association. Diabetes management in correctional institutions. Diabetes Care. 2010;33:S75-81.
17. Scopinaro N, Marinari G, Camerini GB, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care. 2005;28:2406-11. (Pubitemid 41384285)
18. Tejirian T, Jensen C, Dutson E. Bariatric surgery and type 2 diabetes mellitus: surgically induced remission. J Diabetes Sci Technol. 2008;2:685-91.
19. Bose M, Olivan B, Teixeira J, et al. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg. 2009;19:217-29.
20. Padwal RS, Gabr RQ, Sharma AM, et al. Effect of gastric bypass surgery on the absorption and bioavailability of metformin. Diabetes Care. 2011;34:1295-300.
21. Patti ME, Houten SM, Bianco A, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity. 2009;17:1671-7.
22. Laferrere B, McGinty J, Heshka S, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 2007;30:1709-16. (Pubitemid 47036341)
23. Rubino F, R'bibo SL, del Genio F, et al.Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol. 2010;6:102-9.
24. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741-9. (Pubitemid 44629948)
25. Garcia-Caballero M, Valle M, Martinez-Moreno JM, et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with one anastomosis gastric bypass. Nutr Hosp. 2012;27:623-31.
26. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240:236-42. (Pubitemid 38963013)
27. Roger HU, Anna ME. Entero-insular axis. Arch Intern Med. 1969;123:261-6.
28. Creutzfeldt W. The incretin concept today. Diabetologia. 1979;16:75-85. (Pubitemid 9231263)
29. Perley MJ, Kipnis DM. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest. 1967;46:1954-62.
30. Preitner F, Ibberson M, Franglin I, et al. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest. 2004;113:635-45. (Pubitemid 38542513)
31. Timothy JK, Joel FH. The glucagon-like peptides. Endocr Rev. 1999;20:876-913.
32. Fiona MG, Leanne W, Anna KS, et al. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes. 2003;52:1147-54.
33. Juris JM, Michael AN, Wolfgang ES, et al. Gastric inhibitory polypeptide: the neglected incretin revisited. Regul Pept. 2002;107:1-13.
34. Creutzfeldt W. The entero-insular axis in type 2 diabetes - incretins as therapeutic agents. Exp Clin Endocrinol Diabetes. 2001;109(Suppl2):S288-303. (Pubitemid 32577588)
35. Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition. A potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256:104-10.
36. Vilsboll T, Krarup T, Sonne J, et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab. 2003;88:2706-13. (Pubitemid 36724446)
37. Vilsboll T, Krarup T, Deacon CF, et al. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes. 2001;50:609-13. (Pubitemid 32195226)
38. Fetner R, McGinty J, Russell C, et al. Incretins, diabetes, and bariatric surgery: a review. Surg Obes Relat Dis. 2005;1:589-98.
39. Wang W, Wei PL, Lee YC, et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15(5):648-54. (Pubitemid 40847954)
40. Rutledge R, Walsh TR. Continued excellent results with the minigastric bypass: six-year study in 2,410 patients. Obes Surg. 2005;15(9):1304-8. (Pubitemid 41565131)
41. Piazza L, Ferrara F, Leanza S, et al. A laparoscopic mini-gastric bypass: short-term single-institute experience. Updat Surg. 2011;63(4):239-42.
42. Noun R, Skaff J, Riachi E, et al. One thousand consecutive minigastric bypass: short- and long-term outcome. Obes Surg. 2012;22(5):697-703.
43. Lee WJ, Wang W, Lee YC, et al. Laparoscopic mini-gastric bypass: experience with tailored bypass limb according to body weight. Obes Surg. 2008;18(3):294-9.
44. Dang H, Arias E, Szomstein S, et al. Laparoscopic conversion of distal mini-gastric bypass to proximal Roux-en-Y gastric bypass for malnutrition: case report and review of the literature. SORD. 2009;5:383-6.
45. Johnson WH, Fernanadez AZ, Farrell TM, et al. Surgical revision of loop gastric bypass procedure: multicenter review of complications and conversions to Roux-en-Y gastric bypass. SORD. 2007;3:37-41. (Pubitemid 46112396)
46. Azagury DE, Abu Dayyeh BK, Greenwalt IT, et al. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Endoscopy. 2011;43:950-4.
47. Kim YG, Hahn S, Oh TJ, et al. Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis. Diabetologia. 2013;56:696-708.